Shandong Cost Of Revenue from 2010 to 2025
| 600529 Stock | 23.91 0.05 0.21% |
Cost Of Revenue | First Reported 2002-09-30 | Previous Quarter 869.6 M | Current Value 847.7 M | Quarterly Volatility 244.8 M |
Check Shandong Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Pharmaceutical's main balance sheet or income statement drivers, such as Interest Expense of 512.3 K, Selling General Administrative of 176 M or Total Revenue of 6 B, as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Pharmaceutical Valuation or Volatility modules.
Shandong | Cost Of Revenue |
Currently Active Assets on Macroaxis
Other Information on Investing in Shandong Stock
Shandong Pharmaceutical financial ratios help investors to determine whether Shandong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Pharmaceutical security.